BioCentury
ARTICLE | Clinical News

Stool DNA colorectal cancer screening assay diagnostic data

November 8, 2010 8:00 AM UTC

Exact Sciences Corp. (NASDAQ:EXAS), Madison, Wis. Product: Stool DNA colorectal cancer screening assay ( Cologuard) Business: Diagnostic Molecular target: NA Description: Noninvasive stool DNA test t...